no weight loss first month of semaglutide 2 MONTHS ON *GLP-1* RECAP // How I lost 20 lbs, misconceptions + my journey so far! Why Am I Not Losing

Full trial results: nej.md/44U3slP In the FLOW trial, researchers assessed whether the glucagon-like peptide 1 receptor agonist semaglutide was effective in preventing progression of kidney disease in patients with type 2 diabetes and chronic kidney disease

Increased feelings of wellness play an important role in preventing the return to substance use

Always check which estimand a headline number is using before comparing across trials

Objective measurements Depending on your goals, track relevant objective metrics: Body composition: Weight, body fat percentage, circumference measurements, progress photos Performance: Strength numbers, endurance metrics, recovery indicators Health markers: Blood pressure, fasting glucose, HbA1c if using GH or GLP-1 peptides Healing: Range of motion, pain scales, functional capacity tests The peptides before and after article shows what realistic progress looks like

Antioxidants 14 (1), 105 (2025)